More EU debt will not lower public borrowing costs or deepen markets without fiscal-union features, permanent issuance and credible fiscal backstops.
Proposals for common European Union debt have resurfaced, driven by two distinct rationales: financing specific European public goods, and expanding the share of EU debt to deliver broader macroeconomic benefits. This paper focuses on the second rationale, examining whether current and proposed institutional arrangements can deliver the benefits their proponents claim.
We find that the full set of these benefits, which include lower public borrowing costs, improved financial stability and deeper capital market integration, would only materialise under a fiscal union, in which the EU’s fiscal powers are comparable to those of a federal government. Additional temporary common debt issuance for specific purposes within the existing framework would likely fail to deliver most of the benefits. The main reason is that the current investor base for EU debt remains much narrower than that for sovereign debt. This is unlikely to change merely by issuing more debt. A proposal by Blanchard and Ubide (2025) to swap a portion of national debt into EU debt could address this, as it implies a commitment to a sizeable, permanent EU debt stock. At the same time, we argue that EU debt issued under their proposal is unlikely be AAA rated.
Our analysis leads to two main policy recommendations. First, the EU should commit to either permanently roll over the main source of current debt – the NextGenerationEU pandemic-recovery programme – or maintain a minimum level of EU debt outstanding. Second, the EU should take a modest step towards a fiscal union by delegating to the European Commission emergency fiscal powers, including pre-identified revenue measures, that would be activated in the unlikely event that EU debt service falls short. This would strengthen the claim that EU debt is sovereign-like. It would also bolster the prospect that EU debt issued under the Blanchard-Ubide or similar proposals would receive an AAA rating.
Source : Bruegel
Europe pays for innovative medicines through 27 uncoordinated national negotiations, generating access delays, cross-country pricing…
The EU's fiscal rules in force since 2024 are often criticised for their complexity. The…
The signing of the EU-India Free Trade Agreement (FTA) in January 2026 represents a significant…
Trade weaponisation is straining WTO rules, but a semiconductor pact could show how to manage…
Rice feeds nearly 690 million people across Southeast Asia. For decades, governments across the region…
The EU Recovery and Resilience Facility was launched to support post-Covid recovery while accelerating structural…